The CARE Difference: A Smarter Workflow for High‑Risk Screening

Making Waves with MAVES

Where Genomic Insights Meet Clinical Action
Post Image

The CARE Difference: A Smarter Workflow for High‑Risk Screening
  • Frankie Fann, MS, CGC
  • March 25, 2026

Patients with elevated cancer risks are often unidentified within healthcare systems for a variety of reasons, including fragmented workflows and limited access to cancer risk assessment tools.   Danielle Rogers recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry …

Read More
Post Image

The Gene Scene: SMAD4

  • March 24, 2026
Post Image

The Gene Scene: CASQ2

  • March 17, 2026
Post Image

Making Waves with MAVES

  • March 11, 2026
Post Image

The Gene Scene: CALM2

  • March 10, 2026
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience
  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More
Post Image

Navigating NF1: The Moss Family’s Story of Resilience and Hope

  • May 16, 2024
Post Image

Transforming Fear into Action and Advocacy: Our Family’s Lynch Syndrome Story

  • March 22, 2024
Post Image

Peace of Mind: Michelle Majewski Trusts the Patient for Life Program to Share Answers for Her Son Owen

  • November 14, 2023
Post Image

Passing on a Legacy of Health: Ben Huebsch Shares His BRCA Story for Men’s Health Week

  • June 14, 2023

Subscribe

Subscribe to our blog for updates, sent out every month.

Tags